Regen BioPharma Inc (RGBP)

[ADVFN_franknstein]

Small fictive, but honestly interview with Harry Lander regarding the meaning of his shareholder letter.
I:Hello Mr. Lander, let's talk about your shareholder letter. You wrote that to "focus on small molecules NR2F6 seems prescient". What's behind this statement?
H.L. This means that Regen burried alive HemaXellarate and DcellVax.
I: Hmm, ok. Should the mentioning of Gilead's and Bristols latest deals in this sector suggest something similar could happen for Regen?
H-L. Nah, don't be stupid. BP don't really care about what Regen is doing. If you have nothing to show after a year with falling share prices you at least should give your share holders a warm feeling. That's it.
I: Well, you wrote that Regen "elected to continue to develop the NR2F6 program in-house prior to entering into any potential partnerships". Does this mean Regen has enough financial power to fund further developments without even much heavier dilution?
H.L. Nope. This exactly means the opposite. Neither me nor the two hired fund raising firms were able to get a single dollar from BP or find funding. For sure there will be dilution ... massive dilution. Someone have to pay for salaries of Koos, Caven and me
I: Ah, understand. Similar to your last letter where you wrote that future investors won't get shares at historical discounts and then only weeks later shares at new historical discounts were issued, right?
H-L. Now you've got it!
I: Thanks for clarifying, Mr. Lander.